Matches in Wikidata for { <http://www.wikidata.org/entity/Q66084230> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q66084230 description "clinical trial" @default.
- Q66084230 description "ensayu clínicu" @default.
- Q66084230 description "klinisch onderzoek" @default.
- Q66084230 description "клінічне випробування" @default.
- Q66084230 name "Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes." @default.
- Q66084230 name "Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes." @default.
- Q66084230 type Item @default.
- Q66084230 label "Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes." @default.
- Q66084230 label "Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes." @default.
- Q66084230 prefLabel "Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes." @default.
- Q66084230 prefLabel "Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes." @default.
- Q66084230 P1050 Q66084230-9BD946F3-8126-4841-AF7A-CF02635DEE47 @default.
- Q66084230 P1132 Q66084230-6ACB8321-8CCF-4228-BAE6-7C0BFBD97D7E @default.
- Q66084230 P1476 Q66084230-089AFF25-97D4-4404-8C99-9833403570A1 @default.
- Q66084230 P17 Q66084230-32C3E266-8784-46C1-95B4-4C22ECBBACA0 @default.
- Q66084230 P1813 Q66084230-4C991A68-C5B6-46E8-A4C4-910D42AFEEAC @default.
- Q66084230 P2899 Q66084230-BB7E9751-CB83-4362-8E39-6D27BAE43726 @default.
- Q66084230 P3098 Q66084230-70579668-9EFB-46DF-B755-23312AD47088 @default.
- Q66084230 P31 Q66084230-3CDDF1D8-6EC8-48E1-99E2-8DEC4BB672EE @default.
- Q66084230 P4844 Q66084230-ACA0D5CF-29DF-405E-8FAC-B4A095E8EA71 @default.
- Q66084230 P580 Q66084230-5AD9A4A5-2945-4642-B5D3-3580796431A5 @default.
- Q66084230 P582 Q66084230-BD0A17F0-A6D9-4B39-A080-796B3F07C630 @default.
- Q66084230 P6099 Q66084230-71DCEEA7-E562-4AB8-A3EC-2C383F551668 @default.
- Q66084230 P8363 Q66084230-1B43CC41-F7B0-40B5-951C-E5C935C84097 @default.
- Q66084230 P859 Q66084230-10845C1C-6FA1-4F12-B8B5-EE874D77D8FD @default.
- Q66084230 P1050 Q181754 @default.
- Q66084230 P1132 "+797" @default.
- Q66084230 P1476 "A 52 Week, Open Label Evaluation of the Effects of Sacubitril/Valsartan (LCZ696) Therapy on Biomarkers, Myocardial Remodeling and Patient-reported Outcomes in Heart Failure With Reduced Left Ventricular Ejection Fraction." @default.
- Q66084230 P17 Q30 @default.
- Q66084230 P1813 "PROVE-HF" @default.
- Q66084230 P2899 "+18" @default.
- Q66084230 P3098 "NCT02887183" @default.
- Q66084230 P31 Q30612 @default.
- Q66084230 P4844 Q7912612 @default.
- Q66084230 P580 "2016-10-25T00:00:00Z" @default.
- Q66084230 P582 "2018-10-22T00:00:00Z" @default.
- Q66084230 P6099 Q42825046 @default.
- Q66084230 P8363 Q78089383 @default.
- Q66084230 P859 Q507154 @default.